U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H4N2O
Molecular Weight 96.0874
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 4-PYRIMIDONE

SMILES

O=C1NC=NC=C1

InChI

InChIKey=DNCYBUMDUBHIJZ-UHFFFAOYSA-N
InChI=1S/C4H4N2O/c7-4-1-2-5-3-6-4/h1-3H,(H,5,6,7)

HIDE SMILES / InChI

Molecular Formula C4H4N2O
Molecular Weight 96.0874
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair.
2010-12-16
Tautomerism in 4-hydroxypyrimidine, S-methyl-2-thiouracil, and 2-thiouracil.
2010-12-09
A short synthesis of the triazolopyrimidine antibiotic essramycin.
2010-11-29
2-Isopropyl-6-methyl-pyrimidin-4(3H)-one.
2010-08-28
3-Phenyl-2-(pyrrolidin-1-yl)-5,6-dihydro-8H-thio-pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one.
2010-08-25
Titanium(IV) isopropoxide mediated synthesis of pyrimidin-4-ones.
2010-05-21
Comparison of the non-radiative decay mechanisms of 4-pyrimidinone and uracil: an ab initio study.
2010-05-21
Synthesis and biological activity of N(4)-phenylsubstituted-6-(2,4-dichloro phenylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic and antitumor agents.
2010-05-15
Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications.
2010-04-01
A eukaryotic-acquired gene by a biotrophic phytopathogen allows prolonged survival on the host by counteracting the shut-down of plant photosynthesis.
2010-01-28
Role of the carbonyl group of the (6-4) photoproduct in the (6-4) photolyase reaction.
2009-10-06
Formation of uracil from the ultraviolet photo-irradiation of pyrimidine in pure H2O ices.
2009-09
6-Amino-2,5-bis-(pivaloylamino)pyrimidin-4(3H)-one dihydrate.
2009-06-06
An iron(II) dependent formamide hydrolase catalyzes the second step in the archaeal biosynthetic pathway to riboflavin and 7,8-didemethyl-8-hydroxy-5-deazariboflavin.
2009-05-19
Parallel solid-phase synthesis and high-throughput 1H NMR evaluation of a 96-member 1,2,4-trisubstituted-pyrimidin-6-one-5-carboxylic acid library.
2009-03-20
Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors.
2009-03-05
Inhibition of iNOS and COX-2 in human whole blood ex vivo and monocyte-macrophage J774 cells by a new group of aminothiopyrimidone derivatives.
2009-03-01
Pyrimidone derivative inhibits simian immunodeficiency virus-induced apoptosis of CEM x174 cells.
2009-02
Spectroscopic analysis of the pyrimidine(6-4)pyrimidone photoproduct: insights into the (6-4) photolyase reaction.
2009-01-07
Recognition and reaction mechanisms of the (6-4) photolyase as determined by using a (6-4) photoproduct analog.
2009
Synthesis, structure and spectral investigation of hydrogen bonded helical chain in mixed ligand Cu(II) pyrimidone complex.
2008-11-15
Design, synthesis, and biological evaluation of potent c-Met inhibitors.
2008-09-25
Bis[μ-3-(2-hydroxy-ethyl)-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-olato-κN,O:O]bis[aquachloridocopper(II)].
2008-09-13
3D-QSAR CoMFA of a series of DABO derivatives as HIV-1 reverse transcriptase non-nucleoside inhibitors.
2008-08
The mechanism of ureido-pyrimidinone:2,7-diamido-naphthyridine complexation and the presence of kinetically controlled pathways in multicomponent hydrogen-bonded systems.
2008-04-23
The first metal complexes of 4,6-diamino-1-hydro-5-hydroxy-pyrimidine-2-thione: preparation, physical and spectroscopic studies, and preliminary antimicrobial properties.
2008
Formamide as the main building block in the origin of nucleic acids.
2007-08-16
Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.
2007-07-26
Probing the solvent-induced tautomerism of a redox-active ureidopyrimidinone.
2007-06-14
Systematic effect of benzo-annelation on oxo-hydroxy tautomerism of heterocyclic compounds. Experimental matrix-isolation and theoretical study.
2007-06-14
Gas-phase tautomeric equilibrium of 4-hydroxypyrimidine with its ketonic forms: a free jet millimeterwave spectroscopy study.
2007-05-16
How resonance assists hydrogen bonding interactions: an energy decomposition analysis.
2007-01-15
Spectroscopic studies on a novel intramolecular hydrogen bond within the (6-4) photoproduct.
2007
Dimerization and double proton transfer-induced tautomerism of 4(3H)-pyrimidinone in solution studied by IR spectroscopy and quantum chemical calculations.
2006-12-28
UV-induced generation of rare tautomers of allopurinol and 9-methylhypoxanthine -- a matrix isolation FTIR study.
2006-07-20
Analytical and semipreparative high performance liquid chromatography separation of stereoisomers of novel 3,4-dihydropyrimidin-4(3H)-one derivatives on the immobilised amylose-based Chiralpak IA chiral stationary phase.
2006-07
H2, N2, CO, and CO2 sorption properties of a series of robust sodalite-type microporous coordination polymers.
2006-03-20
Involvement of molybdenum hydroxylases in reductive metabolism of nitro polycyclic aromatic hydrocarbons in mammalian skin.
2005-09
Nucleotide excision repair activity varies among murine spermatogenic cell types.
2005-07
Ureidopyrimidinones incorporating a functionalizable p-aminophenyl electron-donating group at C-6.
2005-04-01
A theoretical study on the structure-activity relationships of metabolites of folates as antioxidants and its implications for rational design of antioxidants.
2005-02-15
Phenoxydifluoromethyl substituted nitrogen heterocycles. Synthesis and heterocyclization reactions of ethyl 4,4-difluoro- 4-phenoxyacetoacetate.
2004-02-28
Coordination frameworks containing the pyrimidin-4-olate ligand. Synthesis, thermal, magnetic, and ab initio XRPD structural characterization of nickel and zinc derivatives.
2004-01-26
Xanthine oxidase-catalyzed metabolism of 2-nitrofluorene, a carcinogenic air pollutant, in rat skin.
2003-04
The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2.
2003-03-24
Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis.
2003-01-02
Ab initio study of the (5R)- and (5S)-TT pyrimidine h5(6-4) pyrimidone photoproducts. Implications on the design of new biologically relevant analogues.
2002-12-27
PMT13, a pyrimidone analogue of thiazolidinedione improves insulin resistance-associated disorders in animal models of type 2 diabetes.
2002-09
Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii.
1995-11-09
Structure-activity relationship of ligands of uracil phosphoribosyltransferase from Toxoplasma gondii.
1994-08-17
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:18:47 GMT 2025
Edited
by admin
on Mon Mar 31 19:18:47 GMT 2025
Record UNII
K43V90OY4L
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
4-PYRIMIDONE
Systematic Name English
NSC-1575
Preferred Name English
4-PYRIMIDINOL
Systematic Name English
NSC-157911
Code English
4-PYRIMIDINONE
Systematic Name English
4(1H)-PYRIMIDINONE
Systematic Name English
DEAMINOISOCYTOSINE
Common Name English
4-HYDROXYPYRIMIDINE
Systematic Name English
4(3H)-PYRIMIDINONE
Systematic Name English
4-OXOPYRIMIDINE
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
224-932-4
Created by admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
PRIMARY
NSC
157911
Created by admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
PRIMARY
FDA UNII
K43V90OY4L
Created by admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
PRIMARY
PUBCHEM
20695
Created by admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
PRIMARY
CAS
4562-27-0
Created by admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
PRIMARY
EPA CompTox
DTXSID5063524
Created by admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
PRIMARY
NSC
1575
Created by admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
PRIMARY
CAS
51953-18-5
Created by admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
ALTERNATIVE
WIKIPEDIA
Pyrimidone
Created by admin on Mon Mar 31 19:18:47 GMT 2025 , Edited by admin on Mon Mar 31 19:18:47 GMT 2025
PRIMARY